Skip to main content
logo
Apogee Therapeutics, Inc. (APGE)
Sept 3, 2026 - APGE was delisted (reason: acquired by ABBV)
135.07
0.00 (0.00%)
Inactive · Last trade price on Sep 3, 2026

Apogee Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
10,1865,0942,5781,342-
Market Cap Growth
378.19%97.62%92.14%--
Enterprise Value
8,8994,5151,836919-
Last Close Price
135.0775.4845.3027.94-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
PB Ratio
8.495.643.603.53-
P/TBV Ratio
8.535.643.603.53-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.010.010.020.01-
Net Debt / Equity Ratio
-1.08-0.99-1.00-1.04-1.07
Net Debt / EBITDA Ratio
4.003.153.32--
Net Debt / FCF Ratio
5.283.844.175.258.48
Quick Ratio
26.1726.3818.4019.3015.22
Current Ratio
26.4426.5718.5519.3815.24
Return on Equity (ROE)
-32.45%-31.57%-33.22%-32.18%-
Return on Assets (ROA)
-20.30%-21.11%-23.46%-21.00%-
Return on Capital Employed (ROCE)
-24.90%-31.40%-29.90%-24.40%-23.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-2.89%-5.02%-7.07%-6.26%-
FCF Yield
-2.39%-4.57%-6.69%-5.58%-
Buyback Yield / Dilution
-17.59%-9.96%-120.72%-915.57%-
SEC Filings: 10-K · 10-Q